The Ultimate Human with Gary Brecka - 127. Dr. Mink Chawla: Blood Filter Seraph-100 Shows Promise To End Long COVID
Episode Date: December 31, 2024In this episode, Chief Medical Officer at Exthera Medical and President of Stavro Medical Division, Dr. Mink Chawla, reveals the DARPA-backed breakthrough that's revolutionizing medicine: the Seraph-1...00 filter. This ingenious device packs the surface area of a football field into something the size of your thumb, creating the ultimate biological "honey trap" for everything from viruses to cancer cells. Is this the future of medicine we've been waiting for? For those interested in learning more about the Long Covid clinical trial, they should contact longcovidtrial@lumati.com. The Seraph-100 filter is made by Exthera Medical and the co-inventors of the filter are Robert Ward PhD and Keith McCrea PhD. References: Use of the Seraph® 100 Microbind® Affinity Blood Filter in an adolescent patient with disseminated adenoviral disease A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19 Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry Seraph-100 hemoperfusion for management of severe COVID-19: Assessment of serum and plasma analytes pre- and post-filtration Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals Interactions between heparin and SARS-CoV-2 spike glycoprotein RBD from omicron and other variants. Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsy First-In-Human Rapid Removal of Circulating Tumor Cells in Solid Metastatic Neoplasia by Microbind Affinity Blood Filter Connect with Dr. Mink Chawla: Website LinkedIn Facebook 00:00 Intro of Show 02:33 Dr. Mink Chawla’s Background 04:59 Creation of DARPA (Defense Advanced Research Projects Administration) 10:46 How Seraph 100 Filter and DARPA Technology Have Evolved 18:53 COVID, Removing Virus, and Inflammatory Mediators 19:56 Inflammation as Part of Our Defense System against Infection 24:08 Aging as an Immune-Overload 30:10 17-Year Old Who Had Kidney Transplant and Adenovirus Viremia 34:05 DNA is Retroviral 37:28 Long COVID and Biomarkers 44:09 How Does mRNA Vaccine Work? 51:07 FDA and Its International Harmonization Guidelines 52:42 T-Cell Exhaustion 57:13 Suffering from Long COVID 1:01:37 90% of Cancer Deaths Are From Metastasis 1:05:55 Implications for Longevity and Anti-Aging 1:09:21 Are Studies and Publications on Hydrogen Legit? 1:17:20 Power of Psychedelics 1:19:36 Extending Health Span and Clinical Trials 1:20:34 What Excites and Motivates Dr. Mink Chawla? 1:27:21 Final Question: What does it mean to you to be an “Ultimate Human?” ECHO GO PLUS HYDROGEN WATER BOTTLE BODY HEALTH - USE CODE “ULTIMATE20” FOR 20% OFF YOUR ORDER BAJA GOLD - 91 ESSENTIAL MINERALS PER PINCH! 10% OFF USE CODE "ULTIMATE10" EIGHT SLEEP - SAVE $350 ON THE POD 4 ULTRA WITH CODE “GARY” ELEVATE YOUR WORKOUTS WITH THE ULTIMATE HUMAN STRENGTH TRAINING EQUIPMENT COLD LIFE - BOOST RECOVERY & WELL-BEING WITH THE ULTIMATE HUMAN PLUNGE WHOOP - GET 1 FREE MONTH WHEN YOU JOIN! MASA CHIPS - GET 20% OFF YOUR FIRST $50+ ORDER PARKER PASTURES - GET PREMIUM GRASS-FED MEATS TODAY Connect with Gary Brecka: Website Instagram YouTube TikTok Facebook X.com LinkedIn The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices
Transcript
Discussion (0)
We have certain biologic systems that have enormous redundancy and inflammation is one of them.
Everyone thinks, well, this is such a bad problem. But if you cannot inflame, you die from infection.
Roughly 40% of our DNA is viral and that lots of pathogens that we catch,
they're ones we always had. And when our immune system gets run down,
they just rear their ugly head.
Your immune system is getting beaten up and over time it just degrades.
And things like Alzheimer's, Parkinson's,
all these things which take out our loved ones begin to emerge. Prior to the age of antibiotics,
cancer was rare. So cancer is a disease of success. Sometimes it's a difficult concept for people to
really realize that all cancer, regardless of its former origin, was a healthy cell at one time.
If you are a cancer survivor, they don't ever say this, but every morning they wake up and they ask themselves, is today the day my cancer comes back?
If we could filter out and just give the immune system a break.
I was asked to join this DARPA program in 2013.
DARPA's singular and enduring mission is to prevent strategic surprise.
We want to develop a filter that runs like a dialysis system.
We want this device to remove current virus, current fungi, and the future unknown pathogen.
As a physician, scientist, researcher, where do you see this technology five years from
today?
What I think is the next most important value proposition
scientifically is...
Hey guys, welcome back to the Ultimate Human Podcast. I'm your host, human biologist Gary
Brekker, where we go down the road of everything anti-aging, biohacking, longevity, and everything in between.
And as you just heard, today's guest, well, actually, I'm probably more excited than you
are about today's guest because I have so many questions for him. I am so intellectually curious
about his background, the current work that he is doing, the impact that I believe he's going to
have on the aging, the longevity market, just bio-optimization in general, helping people live
healthier, happier, longer, more fulfilling lives. So you are really in for a treat. Welcome to the
podcast, Dr. Mink Chawla. Oh, thanks so much, Gary. Delighted to be here. Yeah, I've literally
been excited about this for the last six months. We've done some Zoom calls together. You're a very handsome man. You look handsome on
Zoom. Thank you. That's generous. I appreciate that. But when I was actually first introduced
to you and I did a little background and research on you, and I'd love for you to talk a little bit
about your journey to how you got to where you are now, because I think that you are about
to make a major impactful change that may shift the dynamics and the longevity in the functional
medicine world. And we'll talk about that on the podcast. But I read that you had published 170
peer-reviewed articles. Yeah, that's about where it is now, yeah. I mean, I know collegiate universities that haven't put out a hundred.
So first of all, did you start when you were two?
No.
And how did you generate that much valid data?
Well, so my background is I'm an ICU physician,
I'm a nephrologist,
and that combination is unbelievably uncommon.
So people who go into critical care will usually do it with anesthesia or with pulmonary or with surgery.
Doing it with nephrology is a really uncommon combination, really uncommon.
So I did that.
I was at George Washington University Hospital for 20 years.
And that space sort of blew up in real time in front of us.
And it's all about how you can take a very sick patient,
take blood out of their body,
do things to it that helps improve the patients,
put the blood back in.
So it's really advanced plumbing,
pool filter kind of stuff.
Right.
I mean, like dialysis-ish.
Right.
Dialysis-ish.
And that just led to an enormous amount of research going on.
And I also ended up doing some work on a new vasopressor, which is a drug called angiotensin
2.
And that is the drug that led me out of academics.
And I spent five years at a company called La Jolla Pharmaceutical Company, where I was
very privileged to work with an extraordinary team.
And we got the first drug approved for septic shock since the Food, Drug, and Cosmetic Act
of 1962.
Wow.
So that was a great experience and extraordinary people, extraordinary clinicians and investigators.
But the project that sort of led me down to my more dialysis driven days actually started at DARPA.
So I sort of had this full academic life.
And then I went on to work on this team to develop this drug.
And now I'm sort of a pandemic that was coming.
Right.
That wasn't here yet.
Yes.
To actually address this pathogen that was going to be in people's bloodstreams that wasn't in their bloodstreams now.
Correct.
And again, I'm paraphrasing.
It wasn't in their bloodstreams now.
And filter it out effectively with basically the fewest amount of side effects.
That's exactly right.
And it was a wild, wild thing.
So I was asked to join
this DARPA program in 2013. And for people that don't know what DARPA is. Oh, thank you. So that's
a really good point. So DARPA is the Advanced Research Projects Administration. It was developed
after Sputnik. So some of your listeners will not know what Sputnik is. You and I are not going to
talk about our age to discuss why we know Sputnik.
You're my age, you know Sputnik.
Yeah, yeah.
So the Russians basically launched a satellite.
The US didn't see it coming.
We were completely surprised by it.
DARPA was created in response.
DARPA's singular and enduring mission
is to prevent strategic surprise.
So they get a solid budget
and their job is to imagine and dream up what terribleness
can come our way and to do projects and research to be prepared for it. So in 2013, we roll into
a room. I'm relieved of my electronics. You go in and a colonel gets up and says,
in the future, there will be a pandemic. We will not be prepared. There will be no vaccine. There'll be
no drugs. There'll be nothing. And while we're sorting it out, we want to develop a filter
that runs like a dialysis system that removes pathogen. And I am looking at this guy.
What the pathogen is, you know.
Correct. And so he says, we want this device to remove current virus, current bacteria, current fungi, and the future unknown
pathogen.
Wow.
And Doug Silverstein, who's a very good friend of mine who works at FDA, still works at FDA,
was at the meeting with me.
And I turned to Doug and I said, this is effing crazy.
This will never happen.
This is total science fiction.
Yeah.
But it's cool.
Yeah.
You know, it's cool.
And not only were they right about the pandemic.
I mean, eerily.
Eerily right.
Kind of makes us want to go down another road.
That could be a whole separate podcast.
Yeah, I think that could be a whole separate podcast.
And we won't do that.
And the filter that actually worked to do all that was created.
It was emergency use authorized in 2020, and it worked against COVID, and it worked as advertised.
Not surprisingly, initially largely deployed at our military facilities.
So Walter Reed, BAMSE in San Antonio, Eisenhower, Tripler, I mean, all our big centers, Bethesda Naval, et cetera.
And it worked wonderfully. And we are now learning about all the other things this filter can take
out, which is hugely important and valuable. But much of this has been serendipity. And I've said
for a very long time that great technology teaches science. And so we are letting this tech teach us to be really honest for much of the
journey. I mean, I think it's fascinating for me, like this, just this right now, present time
in science, in aging, in mortality, in longevity, bio-optimization, whatever you want to call it.
It's such an exciting time.
I see, you know, there are a few big innovations,
artificial intelligence,
which manipulates 700 trillion independent variables
and creates an actionable result.
Early detection, you know,
we're now talking about, you know,
at stage zero for cancers,
where we've talked about stage one,
if you catch it early,
this is like pre-stage one. And so this combination of early detection, artificial
intelligence, big data, I do feel like the regulatory market is woefully behind and is
going to have a very difficult time keeping up with the pace of innovation. I agree. Because
we've built a whole medical system on the
backs of randomized clinical trials which are five year eight year ten year trials and then
you know animal studies then controlled human trials and then launch and you know usually it's
three four five six seven years before we launch something and then we go oh we made a mistake
yep and the failure rate's high yeah and the failure rate's high and we're 20 years down the road.
That's right.
That's exactly right.
And so the cycle, in my opinion,
is just being vastly compressed.
But I think it's fascinating.
First of all, your background
as an intensive care unit physician
and also having a nephrology concentration
or nephrology expertise
because the kidney is the great filter
of the body. And it can be our best friend or our worst enemy, depending on how healthy it is.
And so this is, you know, getting a window into your brain, you must have automatically been
thinking filtration. How do I filter out the bad and still leave the good?
That's right.
Right? So it can't just be size.
That's right.
Because size alone is going to take a lot of things out of our plasma and our bloodstream
that yes, could be pathogenic. But by the time you get down to the size of a pathogen, a virus,
well, now you've already eliminated platelets and red blood cells and all kinds of immune cells and natural killers.
So you can't just, you know, when you think about this kind of filtration, it's got to be so multifactorial because it's not as simple as people think about air filtration.
Okay, the smaller I make the hole, first I catch, you know, cat hairs and then I catch dust and then I catch mites and then I catch viruses.
We can't do that in the
blood. That's exactly right. And so how did, how did this technology evolve for you? Yeah. So what's
really interesting is that in medicine, since the development of antibiotics, largely we are
allopathic physicians. So we go to a lot of training, usually around 10 years on average,
you know, post-grad four years of medical school residency.
We are the most advanced drug pushers in the history of the world.
We're very good at it.
And we know how to dial in drugs.
But 98% of physicians, we add things.
We give medication.
We give things to you.
There's only two specialties that remove.
Surgeons and nephrologists.
Right? Because we take things out. out now surgeons do it with a knife right and it makes sense like hack out a tumor good we want that
that's fantastic take out a certain part of the brain that's infection tissue totally so
nephrologists since the advent of dialysis which was in 1944 45 we spent a lot of time thinking about how do I take things out of the
body and leave the good stuff? And we have had a very long period of time of working with different
materials that upset the blood less. Blood is not meant to interact with plastic. It does not like
it. And in the early days of dialysis, we would wait to put people on dialysis because the
membranes were bio-incompatible. So the blood would see this surface and it would hate it.
It would get inflamed, complement, coagulation, very bad things would begin to happen. White
cells would get activated. They would become inflammatory. So you had a very rough risk benefit equation. So you're benefiting them by taking out their kidney toxins, but
you're eating a lot of harm for that patient. And so it wasn't a great place to be. Around the 1980s,
1990s in the dialysis world, we moved to new materials that were biocompatible and things begun to get a lot better. But all
dialysis systems, apheresis systems, they, as you point out quite correctly, use size exclusion
to do their job. So an air filter is a good example of size exclusion, a coffee filter,
coffee grounds from coffee, penne from pasta with a colander. These are all size exclusion devices.
This device, the Serif 100 that was developed in the DARPA program,
used a very different idea and they used a concept called surface affinity. So instead of taking
blood and saying, okay, big things go through, small things will take out, they use a different
concept. So I want you to
imagine all of us, you know, adult humans have on five liters of blood in our bodies. That's a
gallon jug plus about 25% more, right? Okay. So you take out someone's blood. You would not do
this. This is very uncool, but you take all the blood out of someone's body and you pour it on a
kitchen table. That's at about a 5% incline.
And you allow all that blood to roll across that surface.
You collect it, put it back into the patient's body.
That is conceptually what this procedure is.
Now, the surface of this filter is made up of a very special surface. And that surface looks like a wheat field
during harvest time.
All these little projections sticking up.
Like the endothelium, like the glycocalyx.
Exactly.
So this is identical to the inner lining
of our blood vessels, the endothelial glycocalyx.
And so it's very biocompatible
because this is what the blood just came from. It came from an endothelial glycocalyx area,
and now it's seeing a glycocalyx, so it doesn't get upset. So this surface is very biocompatible.
Now, the initial insight was that Staph aureus, a very nasty bug that's on all of us, was attracted to this
surface. This surface is made up of heparin. So for the medically literate folks, this is the
same heparin that you use to treat someone with a blood clot, but it's not being used in the same
way. It's on the surface. So heparin coated devices, the heparin is laid down like latex.
In this surface, the heparin is projected up, so it looks just like our glycocalyx.
Wow.
So our glycocalyx is made of heparan sulfate, H-E-P-E-R-A-N.
This is H-E-P-E-R-I-N, but structurally, they're identical.
Wow.
So the initial DARPA program was, hey, it tends to attract bugs, pathogens.
So let's use it.
What we've come to understand is why so many pathogens attach to this.
So it started with staph and gram-negative bugs like Klebsiella and Pseudomonas, and then COVID hit.
And this device binds the COVID virus.
I've seen the COVID studies.
Yes.
Very impressive.
It's very amazing.
But importantly, spike protein has heparin binding sites.
Long COVID.
And it binds amyloid, which is also linked to long COVID,
and it binds circulating tumor cells.
Wow.
And so most people then say, okay, wait a minute. Like,
how can it do all this? Why is it doing this? Sounds too good to be true. It sounds too good
to be true. It doesn't, it doesn't take off heavy metals. It doesn't take off glyphosate. So it's
not a panacea, but for certain things it works really well. So the reason why, and now this is
thesis, but I think it is the Occam's razor explanation, is whether you are
a staph aureus molecule, whether you're pseudomonas, whether you're spike protein,
whether you are cancer, you're invading, you're not in a static system. So blood in your body is
not in a bucket hanging around. Your cardiac output, as you know, is five liters per minute at rest.
Five liters per minute.
So your bloodstream is a rushing torrent all the time.
Blood's moving.
It's moving fast.
And you see a movie and someone gets shot and then the artery and blood spurting out.
That's real.
Like that is a legit thing.
Like blood is moving at a really high pressure and pace.
So evolution has taught whatever invasion-minded particle,
the first thing you need to do before you take out your own unique attack machinery is you got to steady yourself.
Like you were getting out of a rushing stream, you got to grab a rock.
Right.
So all of these things have developed suction cups to grab the glycocalyx.
Wow.
That's the wall of your vessel.
That's the wall of the vessel.
Exactly.
So they're rushing by.
They're like, I need to get out and invade.
So they put their suction cup on and they start to do their business.
We are the most massive decoy bait and switch device in the history of biology.
Wow.
So all these particles enter the filter and they think they have hit a home run. They're like, I'm here the history of biology. Wow. So all these particles enter the
filter and they think they have hit a home run. They're like, I'm here. I found it. Yeah. Because
so there's lots of surface area in this filter. 40 meters square, the size of a football field
of surface in a tube about the size of this thing. Really? Yeah. And as the blood goes through there,
there are all these heparin binding sites that it can attach to. And they all attach to thinking that they are home free, not realizing that filter is going in the trash.
Right.
Wow.
And it works very effectively to do this.
And so it started with the DARPA program.
We got smarter.
We saw it working for so many things.
And I think we now understand why.
So it is still emergency use authorized for COVID. Yeah. So in Europe,
it is fully approved for pathogen reduction and it has been since 2019. The U.S., and this is not
a knock against anyone, but we tend to lag behind approvals in other places in the world.
It was emergency use authorized just for COVID and it still has that use. And we are currently submitting our full approval to the FDA
and we hope to have full approval for COVID and hopefully secondary sepsis in the next six to 12
months. So would you say that the positive outcomes, and I will actually put a link to that
study, it's published because I've read it myself, but for those of the folks that are listening
that are not really familiar with it,
would you say that the benefits were coming from the direct reduction of the viral load,
the SARS-CoV-2 virus being reduced?
And then there are other ancillary benefits too, like are you removing inflammatory compounds, cytokines,
or other things from the blood that are helping the immune system to calm down and stop
overreacting so it's interesting is that we remove the virus itself which is a very good thing and
there's lots of reasons why that's a good thing but we also remove inflammatory mediators and
i'll get a little bit into the weeds here but things called s-flit and other things called
damps and pamps and um we'll leave links to this for everyone, you know,
so they can go read about it if they're really interested.
But these are danger and pathogen-associated molecular patterns.
And these are basically things that tell the immune system to be upset.
And so I think what people need to understand is we have certain biologic
systems that have enormous redundancy, and inflammation is one of them.
And everyone's heard about inflammation.
They're like, go on a low-inflammation diet. This person's inflamed. They have this lupus.
Inflammation is killing them. And everyone thinks, well, this is such a bad problem. But
if you cannot inflame, you die from infection. So inflammation is part of our defense system
against infection. And you remember when we were all cavemen and women,
we didn't have antibiotics.
Right.
So you needed inflammation to protect you.
So we have lots of redundancy
in our inflammatory pathways.
And this is to protect us.
This is evolutionary biology at work.
So not only does your bloodstream and blood
respond to a fully intact bacteria, a fully intact virus, it will respond to a particle of it, a piece of it, a piece of bacterial DNA the body can recognize.
And it recognizes all these things.
In fact, the body can recognize mRNA.
So the mRNA vaccine had to be modified because this system called the Toll-4 receptor
would recognize it and stop it. So they had to change the actual structure of the mRNA to have
it get past our defense network to have it work. So all this redundancy is there and the filter
removes a lot of these things that get the
immune system upset.
So it has an anti-inflammatory effect, but it's removing the source of the inflammation.
Wow.
Hey, guys, I'm really excited to announce this.
Perfect Aminos has gotten a serious upgrade.
They've added nucleotides, the building blocks of our nucleic acids, DNA and RNA.
And this is important.
We know essential amino acids are the building blocks of protein and collagen.
Having all the essential amino acids in the correct ratio is necessary for complete protein synthesis without the caloric impact.
But if we want perfect protein synthesis, we need to look at the process of protein synthesis itself.
Because if the process is faulty, we won't get the correctly made protein, collagen, fibrin, or the red blood cells in our bloodstream or our muscles.
We can even stop creation of specific proteins, which can affect us in so many different ways.
Our DNA and our RNA are what direct protein synthesis, building new proteins.
If our DNA or RNA get damaged from toxins, harmful bacteria, or just plain aging, we get faulty
protein synthesis. So cells, enzymes, and hormones are less functional and we get premature aging.
By adding nucleosides and nucleotides, the building blocks of the nucleic acids DNA and RNA,
our cells get exactly what they need to help repair faulty DNA and RNA and improve the process
of protein synthesis itself. This is next level science, and you need to try these.
Now let's get back to the Ultimate Human Podcast.
Yeah, because, you know, I've often said inflammation is the root of all evil. I mean,
in fact, there's a theory, and I'm paraphrasing the theory now for a moment. I talked to Peter
Diamantis about this on our podcast. He was on the podcast right before you. He's, by the way,
huge fan of yours. Oh, Peter's awesome. Huge, speaks very, very highly of you. And I speak
very highly of Peter because I just think the world think the world of him. We had many podcasts on Peter Diamantis right before, right before the
cameras started rolling. I just, I love what he's doing in the world. You know, with the,
with his functional medicine clinics and, and the amount of money he's raised for specialized
research and some of the challenges that he hosts for innovations and biotechnology. I mean,
very interesting left brain, right brain guy. That's just got a big heart and really truly
wants to, in my opinion, change the face of humanity. Yeah. I just think what I love about
Peter more than anything, aside from how gifted he is, is his intent is so clear. Yeah. What he's
trying to do. Yeah. And then he just gives you a good hug too oh yeah good guy
very strong guy he's a good guy very strong but um so one of the things that we talked about was
sort of this emerging view of um aging as an immuno overload yes you know like a slow
progressive decline in the immune system's ability to fight on so many
fronts right you take an infant that hasn't been exposed to pesticides herbicides insecticides
glyphosates preservatives you know topical hormone disruptors and all of these other
chemical synthetic pharmaceutical compounds that their immune system wasn't meant to fight and then
you add to that its daily activities protecting us from
all the bugs and the pathogens and, you know, monitoring us for invaders. And I don't think
that people really realize how much the immune system does on a daily basis that is not directly
fighting the invaders. That's right. You know, just cleaning up our own senescent cells. Surveillance.
Yeah. Surveillance. Surveillance is hard. Surveillance is a lot of work to go around and check everything every day and make sure everything is good.
Something is bad to pull it out and get rid of it. Yeah. And so do you subscribe to this,
this theory on aging that amongst other things, it is the immune system's inability or progressively
weakening ability to defend itself on so many fronts.
There's just so many things in our blood that it's got to worry about.
Oh, I think that's very right. And I think that a good example of this is
prior to the age of antibiotics, cancer was rare. So cancer, not exclusively, but largely
is a disease of success. You didn't live long enough to get cancer.
Before the age of antibiotics,
the average people's lives were like 40.
And people would die with cancer,
but they didn't die of cancer.
So the immune system can get overwhelmed by bacteria.
But now with antibiotics,
it has all these other responsibilities
and clearing senescent cells,
getting rid of prec-cancerous cells
but now it is getting inundated with at least in america a major food problem yes this ultra
processed food thing is a disaster no i am very late to this anyone who's watching this who knows
me is like mink is this is the tasty he would eat tasty cakes and diet coke on rounds
he's telling us no in the icu anyone anyone who saw me on rounds at the gw icu knew i would go
through three or four diet cokes on rounds i would be eating horrible for these are all bad habits we
pick up in our and i'm not defending any of, but it's taken me a very long time,
too long, frankly, to come around to this insight.
But your immune system is getting beaten up and over time it just degrades.
Right.
And that degradation is harmed by metabolic diseases, diabetes, you know, all the stuff
that comes with obesity.
It comes along with not being fit, lack of muscle know, all the stuff that comes with obesity. It comes along with not being
fit, lack of muscle mass, that heart. So all these things, which you are a huge proponent of,
oxidative stress, all these things wear against the immune system and the gaps and the defense
begin to open up and things like Alzheimer's, Parkinson's, all these things which take out our loved ones
begin to emerge. And so I totally agree with this general thesis. And I think there are
concrete things we can do about it. And I think what's really interesting is the technology that
you've developed, the serif filter, you know, again, I'm oversimplifying, but what it does
is it removes some of the landscape that the immune system is fighting on, right, I'm oversimplifying, but what it does is it removes the, some of the landscape
that the immune system is, is fighting on, right? I mean, because if you can filter out things like
viral pathogens and, um, inflammatory compounds and even mold or mycotoxins or, um, circulating
tumor cells, which, which, you know, it's sometimes a difficult concept for
people to really realize that, you know, all cancer, regardless of its former origin,
was a healthy cell at one time. That's right. Right. I mean, it was a healthy liver cell and
its metabolism shift to becoming sick, or it was a healthy lung cell and something caused it to
shift its metabolism. There's lots of reasons that cause that, but these were still at one time,
healthy cells. So these are not really things that are happening to us. That's right. They're
things that are happening within us. Right. Yeah. And so if we could theoretically filter out and
just allow the immune system, give the immune system a break, give it some support and some love it would be able to refocus on that's right so much
of the reason why we think that this device helps people is based on something that i had very wrong
at the beginning so um there's a very famous richard feynman quote that i'm fond of and it
says religion is a culture of faith and science is
a culture of doubt. And I like that. I think that's very true. So in certainly my academic
life, we are taught to be very cynical, to be very, you know, just, are you sure? Show it to
me again, show it to me again. And I think that's good. During the DARPA program, I said,
listen, every single bug is different.
How are we gonna find one thing to remove all of it?
And I said, even if we did, let's buy some,
imagine some miracle, ended up happening.
Now, I grew up in New Jersey.
I was born in Philadelphia, I grew up in New Jersey.
So I suffer from what's known
as chronic foot and mouth disease.
Because I say things very boldly, obnoxiously, and I eat, have to eat my words. My foot ends up on my mouth. So I have
chronic foot and mouth disease. So I had a very famous moment with, with this device. I said,
this will never work. And I said, here's the reason why I don't think it'll work.
If you have pneumonia, which is a Klebsiella, which is a very nasty bug,
and your blood is filled with Klebsiella and I remove all of it, as soon as the procedure
is done, it's just going to come right back. It's going to refill everything. And we had a very
powerful case which proved how this works very clearly. So we had a young woman, she's 17 years
old. She has a kidney transplant and she has adenoviral viremia. So adenovirus is a very nasty bug. It tends to pick
on people who are immunocompromised, but not exclusively. She had 10 million copies per
milliliter in her blood of adenovirus. This is a published case report. You'll put in the notes.
I'll put it in the show notes.
And this is associated with a 90 to 95% mortality. She's 17. She should have died. The physicians got very desperate.
They put our filter on and it went from 10 million to 2 million after the first procedure.
Wow.
Then it went from 2 million to 200,000 in the second.
And then they stopped treating her with the filter and it all went away.
Now they had a kidney biopsy.
There's adenovirus in the kidney.
Okay. And there's adenovirus in the kidney, okay?
And there's adenovirus in the blood.
So we clean up the blood and then it all got better.
So what happened?
Well, what happens is the immune system traffics to target areas based on cytokines.
So when you're inflamed and these things that make us sick,
this is not an accident. This is evolution at work. This is how the cell figures out how to go to
the cells that are getting attacked, send out a signal. And the signal is like a scent.
And that scent is taken up by the white cells and they can traffic down that scent to find
where they should go.
Well, if your bloodstream is filled with pathogen, your immune system is in the bloodstream and there's all these cytokines, inflammatory meteors everywhere. So when we mop up the bloodstream,
the immune system redeploys. That is powerful. You have the same number of soldiers, but you're fighting fewer enemies.
That's right.
It's the cavalry to the infantry.
We now give them enough support
so they can go and take care of everything else.
So to your point, from the potential,
if you look at what are the things
that really cause problems,
Epstein-Barr virus has been linked to MS,
HSV to Alzheimer's. All these viruses are
linked and we don't clear them. And as we don't clear them, the body begins to chronically inflame
to them and then terrible things happen to us. So if we can not just move from this inpatient space
where this filter has started, we're now moving into the outpatient space. We're starting a long COVID clinical trial right now. I want to talk to you about that.
And we're seeing extraordinary results from people. We have people with chronic EBV,
chronic Lyme, and we have these cases where it's like, wow, this is... So if you can take a person,
so in the future, we aspire to take people with this like tick-borne illnesses that can't clear it through modern medicine.
We can now bring something to bear to help the immune system reboot, get back on it.
And even though it may not be getting 100% out because we know that viruses will retreat to the dorsal root ganglion, right?
And so while there may be a high viral load for a period of time in the blood and you clean that up, you can resurge, right?
For sure.
But the most important thing is just like HIV, we have not cured HIV, AIDS.
I practiced at a time where many, many people died in front of me with AIDS that I watched highly active retroviral therapy come to bear.
Magic Johnson is alive and well and he's a
billionaire and he's killing it yeah and he still has hiv so to your point precisely if the immune
system can put that virus back in jail i don't care right he just can't be meandering the streets
right you know shooting people yeah that's the problem is to give it enough of a leg up that it goes
dormant i mean i i think a lot of people don't realize too that roughly 40 of our dna is viral
and that that yes you know lots of pathogens epstein-barr not really um pathogens that we
catch the ones we always had and when our immune system gets run down they just rear their ugly
head right like that's exactly right come back as eb their ugly head, right? Like model can come back as EBV
or chicken pox can come back as shingles.
8% of our human DNA is retroviral in origin.
Retroviral, yeah.
Our genome has retrovirus in it.
And when you get very, very sick,
those genes start coming out.
Now there's probably some evolutionary reasons why we
incorporate them in because it has a higher mutation rate so that helps us evolve a little
faster really a fascinating point but it's why molecular biology yeah we have viruses in our
strand of dna totally and they replicate in silence from grandfather to to son to grant like
on and on it goes yes and they, and it has given us an advantage,
but like every advantage, it can become a weakness.
It can become a vulnerability.
And so I very much agree with this notion
of being able to surveil patients
if they have chronic viremias,
if they have chronic tick-borne illnesses,
this I think is going to be a really powerful tool.
I think so too.
In fact, I'm going down to get my filter this, this month or early next. Um, my wife's doing the same thing.
We're going to, you know, get the, uh, um, hook up to this. Yeah. You guys are going to be in the
clinical trial, which I think is great. Yeah. I'm super excited about that. And I'll let you guys
know how it goes. Um, and I'll do some pre and post, uh, you know, some biomarker testing. What,
what kind of, um, for those people that are a little bit more familiar with blood biomarkers,
what kind of biomarkers could we look at pre and post filtration?
And what could we expect to see after filtration?
Let's say somebody's healthy.
And then I want to talk about long COVID.
Because long COVID, what did I read the other day?
27 million people or so.
Oh, yeah.
Still affected by long COVID.
It is astonishing what those numbers look like.
So I think it depends on why folks are getting treated.
So people with acute infection or chronic infection,
if you happen to have PCR positive viral particles
in your blood, then a very easy thing to do is say,
hey, did we take that titer down?
Do we make it undetectable? And
we've done that. We've had cases where people were EBV positive and then they were done,
they were EBV undetectable. So that's like an amazing cool thing. For people with chronic Lyme,
we've had some really extraordinary case reports on this. And for them, you can't measure Lyme so
easily in the blood, but there's these other Lyme surrogates.
So I think it's a little personalized.
In patients with circulating tumor cells,
so the first, you saw the publication,
which is unbelievable.
It really is.
My dear friend, Vedran Prusnek,
who's in Zagreb, who did the first study with Sonia Illich,
the data are just amazing. It is incredible. If I had a loved
one that had cancer right now. That curve to drop CTCs is just mind-blowing. So we've press released
our first experience with five pancreatic cancer patients in Oklahoma. And what was stunning about
them is all the patients were supported in improvement in appetite, less pain, and their
complexion improved. So to get back to your original question, what to measure pre and post
depends on why you're getting it done. And I think for long COVID patients, I think looking at their
markers of inflammation, simple to easy measure things like sed rate and your C-reactive protein,
I think are good starts. I think we would want to do more advanced stuff
for people who have it available in the clinical trial.
But my main interest,
and this is something that I'm going to hope
to work with you on,
is people need to be able to measure spike protein.
Yes.
And it is not easily available.
Yes.
And just the way you've made methylation stuff
more available,
I really feel like being able to measure.
If you feel like poo and you think you have long COVID, well, you may not have virus in your blood.
But if you have spike protein in your blood, Houston, we have a problem.
Yes.
And this is an uncomfortable conversation for many, but the spike protein may not just be from a COVID infection.
It could be from a persistent vaccine producing spike protein.
I've said that too.
I mean, I've also said that the terms long COVID and vaccine injury could be synonymous.
I think in some patients that certainly could be the case. But what's really cool is the mRNA vaccine spike protein is you can differentiate it from wild type with a very sophisticated assay.
It's not easily available.
And I don't want to jump too much into the weeds on it.
And what we can talk about, and I hope we will, is the mRNA that you get from a vaccine is-
Is synthetic.
Is synthetic, and it's slightly different.
The sequence is different by two amino acids.
And that you can actually detect.
That is phenomenal because-
So I could actually measure spike protein in someone,
and then I could do a really expensive,
sophisticated sub-analysis and tell you if that
came not like i differentiate infection or i can differentiate pfizer from modernas wow
which is wild right that is so this signature is so clean you can differentiate wild from pfizer
from moderna hey guys i'm beyond excited to introduce something that's going to transform
your nutrition game a new protein bar formulated by me, created in partnership with Body Health.
Now this is the kind of protein bar I would want in my own backpack. In fact, as I head out on the
great world race, it's going to be in both my son's and my backpack. It is packed with perfect amino,
the same essential amino acids I use every day for up to 99% protein absorption.
Clean, plant-based protein, energizing MCT oil, and a powerhouse organic fruit and veggie blend that will fuel your body at a cellular level.
And guess what? It's naturally sweetened with monk fruit for that minimal caloric and glycemic impact.
Whether you're hitting the gym, grinding through a busy day, or you just need that nutrient dense boost, this bar is my go-to and your new secret weapon. This is not just any kind of
protein bar, guys. If I formulate a protein bar, it's going to be made out of nutrient dense
whole foods. And that's what we accomplished here. And if you're part of my Rule Breaka community,
you'll also get an exclusive discount. So snag yours now before they're gone. Your body and
your future self will thank you. Links to my protein bar and my rule break of VIP community
will be down below in the description.
Now let's get back to the Ultimate Human Podcast.
And just super fast, not to do a whole lesson on cellular biology,
but our DNA sends messages into the cell, messenger RNA, right?
So it transcribes these messages.
And for lack of better words, the
vaccine is, in some cases, is an mRNA vaccine. And that vaccine is a synthetic copy of that message.
That's right.
And so it's not a natural organic copy that was created by your DNA and then thrown out of the
nucleus into the cytoplasm of the cell. This is one that was injected into you synthetically to elicit what they hoped would be the same response.
Right, so let's, I'm gonna explain this in a way
I think hopefully is accessible to everyone.
So the way to think about this is almost every vaccine
prior to this new version, prior to the mRNA vaccines,
were made by taking a bunch of,
let's just use viruses to keep it clean.
And the first thing you have to do is you have to make a lot of virus to make the vaccine. And the way your body works at this is our immune system is so adept,
it recognizes specific molecular patterns like you and I recognize faces.
So you can differentiate two identical twins. Parents
can do it. They can look at their face. They can see it. Our immune system is so good. Different
parts of different viruses, which are called antigens. So the antigen, which is the foreign
product that your immune system responds to, the face on it that it actually sees is called an
epitope. Okay. So that's the epitope. The body recognizes
the epitope and says, okay, I see that face. That guy's a bad guy. I'm going to go get him.
That is the basis of all vaccines. So what happens is we say, okay, for let's say, you know, polio,
okay. Or hepatitis B is probably the best example. There's one face. And if I can get the body to make antibodies to that epitope,
I can actually make this person immune to this.
So what you have to do now is you have to make metric tons of these little faces.
That is really expensive.
And that takes a lot of time.
Now, I'll tell you a funny story.
When I entered from academics to industry,
due to my chronic foot and mouth disease, I was at this big meeting and we were talking about how
this one company was having difficulty making some product. Now, at the time, I didn't know
that 80% of FDA denials come from not being able to make your product correctly because it's really hard i
didn't know that at the time okay had i known that i wouldn't have said what i i said which
i'm going to tell you what i said so they're complaining they can't make this thing and it
was a really great drug and i'm like how hard could it be it's yellow and blue play-doh makes
green yeah but that was the wrong thing yeah he didn't make any friends. Making stuff is really hard.
Now, when you say that at a large public meeting and your chief medical officer of a company,
that comes back to bite you on the ass forever.
Oh, yeah.
And I deserved it.
And so I get like Play-Doh, like joke things from these guys.
I mean, it's fine.
I got it.
Oh, my God.
They send me like, you know, it's so easy.
Even a CMO can do it.
Like these very funny, you know, joke memes, you know, on Play-Doh.
But making stuff is really hard.
So this is where the mRNA vaccine comes into play.
So the idea is it's expensive to set up a factory.
It's expensive to take all this virus and make all of it.
Instead of having a factory make it, let's have the body make it. That's how the
mRNA vaccine works. So the trick and why the technology is really slick is we, all our cells,
make proteins. And there are little factories inside our cells called ribosomes. And they are
protein makers. That's what they do for a making. We need protein. We make muscle. We make antibodies.
And these little guys, this is what they do for a making. We need protein. We make muscle. We make antibodies.
And these little guys, this is what they do for a living. So they get a set of instructions from the nucleus, the brain of the cell, and that is message mRNA.
So the message goes from the nucleus to the ribosome.
So the blueprint goes from the brain to the factory, the ribosome, make this protein. So the idea is let's hijack that ribosome and have it make this face so that the body will respond to it.
So we bypass the factory.
The body is the factory.
Brilliant.
Okay, here's two problems that happen.
So the first problem is viruses.
I've been trying to do this to us for a long time too,
even before we came up with this idea,
viruses were doing it.
Well, that's what they do.
They hijack your cellular biology, right?
They're not really living things.
So our immune system can detect message RNA
and they attack it.
So when we tried these original mRNA vaccines,
they didn't work because the immune system would see it
and take a big billy club and hit it.
Okay.
So it didn't work.
So the mRNA vaccines, in order to trick the immune system, they swapped out the base pair that the immune system could recognize.
It's called uridine.
And they swapped it out into pseudo-uridine.
So the immune system doesn't see it.
Ah.
Doesn't see it.
And then it can go into the cell and do its business.
The problem that the people who have been really worried about the mRNA vaccine is,
how does the ribosome factory know to turn off?
Right.
Since it's a synthetic message, it's not degrading.
So you just sent a blueprint to a factory.
Where's the foreman who says,
Hey,
you're making,
we've made enough of this.
And this stuff you're making is bad for you,
by the way,
right?
Spike protein is bad for you.
It comes from a virus.
It is,
it has clearly been demonstrated to cause problems for the heart,
for the brain.
It's amyloid genic.
Spike protein is bad for you, period, full stop.
Okay.
So it's okay if you're making a little bit of it to have an immune response.
Well, how do you turn it off?
So that's the first problem.
So a lot of people who think that the vaccines cause long COVID are of the belief that the vaccine doesn't turn off and continues to make
spike protein. How you prove this is probably provable with this advanced assay, but I've not
seen good research that demonstrably can say that that's true or not true. It's an open question.
Our filter removes spike protein. Wow. And so we think for long COVID, to the degree that
spike protein is a large component of long COVID, we're going to try and see if that can help people.
So that makes a lot of sense. But the more interesting data that's come out that's a bit
unsettling is the pseudo-uridine doesn't work the way uridine does. So there's a reason why evolution,
or the Lord our God,
depending on your spiritual preference,
uses uridine.
It's because it's a really good blueprint.
Pseudouridine creates errors.
Okay, so I want you to imagine how a ribosome works.
So a ribosome makes a protein,
and every protein starts looking out like a lighthouse.
So you take a bunch of bricks,
and you put them in circles until you get a big cylinder until it goes all the way to the top.
And then that goes on and can do a bunch of other wrapping and become a much more complex thing.
But it starts as a spiral.
It goes in order.
So the order is very important.
And you have four different pieces of code. Uridine is one of them.
And it puts about 25-ish types of amino acids in the place.
So this pseudo-uridine causes what's called frame shift proteins. And we'll put a link
in this Nature article. This is a very top journal. So the top journals in the world
are Science, Nature, Cell, New England Journal, Lancet, JAMA. This is in Nature.
So this is a top group of folks from Cambridge and the UK,
and they are showing that the mRNA vaccines create frame-shifted protein.
So this is not the spike protein.
It's something really similar to a spike protein, but not exactly.
The error rate is 8%. Now, I helped work with a team that developed a drug called angiotensin-2.
If I went to the FDA and said, 8% of our vials will have something else,
what do you think they would have thought about that? No can do. That leads to what's called a CRL, a complete
response letter, which is no. They would say, okay, that's nice. Go back and fix it. Okay.
To give you an idea of how stringent the FDA is and should be, we have these things called the
international harmonization guidelines, called ICH. So in a phase one study,
I'm going into people for the very first time.
If I have an impurity of greater than 0.1%,
the agency insists that I characterize it.
Really?
I don't have to,
I don't have to tell you what it does.
I might have to tell you what it is.
Is,
is,
is it a bottle?
Is it a cap? Is it a cap? Is it a microphone?
What is this thing? 0.1%. This is giving you an 8% error rate and we don't know what it is.
So there's a lot of people who are very upset about this. This is going into people. We don't
know what these proteins are or aren't. To be fair, there's no obvious data that shows that it's bad for you.
I'm not a big fan of, I'm going to give it to you. I don't know.
Right.
Okay. I was thinking for myself here.
Did you get the vaccine?
I got to, my wife did, my kids did. And knowing what I know now, for at least mRNA, I wouldn't.
Yeah.
I don't want frame shifted proteins in me. And they, for at least mRNA, I wouldn't. I don't want frame-shifted proteins in me.
And they actually looked at real patients,
patients who got a vaccine that doesn't cause frame-shift proteins,
have no evidence of antibodies frame-shift proteins.
30% of the folks who got the Pfizer vaccine
had evidence that they had frame-shifted proteins in their body.
Wow.
This is nature.
So please look at the paper and double check me. But this is,
I mean, I wouldn't be surprised if the FDA didn't update the label for them on this.
Wow. Once they get their hands on this, because I don't think an 8%, I don't know,
sits that well with anybody. That's a big number. And considering that 0.1 is the standard. Yeah. And also that this spike protein in overabundance is now being directly linked to all kinds of, you know, diffuse vasculitis, dystonia vasculitis.
So there's a beautiful paper.
It's such a myriad of.
It's clots.
It's brain fog.
But I think the best paper on this is in Circulation, which is a top journal out of the Mass General, Boston Children's Hospital.
So a very reputable institution.
And they looked at people with post-vaccine myocarditis.
And they looked at patients who had gotten the vaccine, who didn't have myocarditis, and those who did.
All of them had very similar T cell responses and similar antibody responses.
The folks with myocarditis all had free spike protein in their blood.
The controls had none.
Wow.
So this is not gold level proof or platinum level proof,
but it suggests that the spike protein is the culprit.
What's more concerning to me is if you have antibodies, why aren't they binding the spike protein?
Yeah.
Like that's weird.
Right.
If you don't have antibodies, okay, fine.
Is it because of the synthetic nature of these additional amino acids?
It's possible.
That could be part of the reason. The other reason is,
is that there's a clear concept
to your original idea
about the immune system
getting its butt kicked over the years
called T-cell exhaustion.
Yeah, T-cell exhaustion.
Right, and you're very familiar with this.
Exactly right.
And T-cell exhaustion is a very fancy term
for saying the immune system
is seeing so much of the bad guy,
it just stops reacting to it.
And I'll give you an example of how the body does this.
So imagine you go into a gas station
and you smell gasoline, which is normal at a gas station.
And for whatever reason, you're stuck at the gas station
for 35 minutes waiting for somebody.
You will notice over 30 minutes,
the smell of gas will appear less to you.
Right.
But the smell of gas has not changed.
Just tachyphylaxis.
Right.
You just start turning off to it.
Your immune system does the same thing over time if it sees a lot of antigen for a long time.
Wow.
It's called T-cell exhaustion.
It shuts off.
So if you're making too much of anything, too much spike protein, right? Your immune system just turns off to it.
This is what happens in cancer.
There's so much cancer.
It's different.
Your immune system should be screaming and yelling to get after it.
Right.
It doesn't.
Now, in the transplantation world, we want this to happen.
We want the body to accept the new organ, but we want the immune system to still look
for bugs.
Right.
This is a concept called tolerance.
So we want the new organ to be tolerated.
But that thing that allows tolerance
allows you to tolerate things you should not tolerate.
Right.
And so what we think our filter can do
is by removing antigen is to create intolerance. Wow. So this could actually
help someone tremendously with long COVID, long COVID suffers, whether the long COVID is coming
from the vaccine or from the infection. Yeah. A year from today, I aspire to have very high
level data. I want your help in developing a spike protein assay that anyone can access.
That's easy
because right now it's almost impossible to get it. If you're suffering from long COVID,
I think one of the big things, and you deal with this in your personal practice,
is randomized controlled trial data is our North Star. Right. Right. So in medicine,
physiology is our North Star and from a data level, it's randomized controlled trial data.
And it should be.
Okay.
Let's be very clear.
I'm not deviating from this position whatsoever.
The problem is RCT level data that shows you something you can do to help somebody is not
available for many, many patients. If you have chronic Lyme, if you
have chronic whatever, the modern medical RCT level data does not offer you very much. And long
COVID is in that spot. There's a few RCTs that suggest maybe SSRIs can deal with symptomology, but none of it is dealing with the core problem, whatever it is. So my thesis, this is now hypothesis, is that spike protein
and spike protein products or consequences like amyloid are largely responsible for what we call
long COVID syndrome. I don't think everyone with long COVID
has a spike protein problem,
but I think many of them do.
I would agree with that.
And you can, with this filter,
you can trap it and get it out.
I think so.
We really think that's a real possibility.
Which is, you know,
for the 27 million people out there
that some of you are listening that have long COVID,
that's real hope for them.
Because like I said,
the clinical trial that you're going to be in is set up and we're looking to
expand it farther.
And we think this could really make an impact for folks.
Look,
we have had people under an IRB,
so under a formal IRB program,
under compassionate use with long COVID,
get the filter. Now, my main
disappointment for myself and our team is we don't have the spike protein up and running due to
pre-post to show that they had it and now they don't have it. But clinically, their brain fog
has improved, their fatigue has improved. And so clinically, we're seeing real benefit. And so this is a good first sign to really get after it.
Yeah.
And so, you know, we're a very small company, but we're getting after it.
Yeah.
And I love that you're getting after it because I don't think there's a lot of answer for people that are suffering from long COVID.
We have so many clients that are suffering from long COVID, whether it's, we'll just refer to it as vaccine injury or whether it's the long, you know, COVID from a prolonged infection.
For sure. I refer to these folks as medical pariahs
because the modern medical system has nothing for them.
And I'm part of that system.
And it is discouraging to have someone who's in pain, who's suffering.
And it's like, we got nothing for you.
And I think that when I was in my academic life,
and I think this is very, shows a deep
lack of empathy, to be honest, was I didn't think what happens to that person when they
leave my office.
Yeah.
Right.
Because I kind of said, hey, this is my expertise.
This is what I told you.
But I didn't think, what is this person going to go do now?
Right.
And the answer is they go and seek out answers that they can seek out because
the modern system says, I don't have randomized controlled trial data for you.
I acknowledge your suffering. And then an AI program, you know, denies their care. Right.
That's what it's come to. Yeah. Yeah. And I think that, you know, the what we're starting to see now is that because something is not directly causal, that, you know, very often we say, well, if there is no direct link, if we cannot link the vaccine to the spike protein to this outcome, then we can't say that it's the spike protein or it's the
vaccination.
I like the fact that you admitted that you wouldn't have gotten vaccinated, nor would
you have let your children or your wife get vaccinated.
Knowing what I know now.
And I think that the frame shift protein thing really bothers me.
To have that kind of unknown in the equation is something I'm not comfortable with.
And I will not take an mRNA-based vaccine
until this issue gets durably sorted out.
No, because the next set of mRNA vaccines
are going to be used for cancer and other diseases
where you're not going to just take two doses.
You're going to get 10, 20, 30, 40.
Like, you're going to be taking them forever
because they want to keep boosting your immune system
to keep responding.
Well, if you don't know that this
thing is making what you say it makes, every time you put it in, you're getting a random protein
generator effect, which doesn't, I'll speak for myself because I don't want to speak for my
company on this or anyone else, but from my level of expertise does not sit well with me.
Right.
Does not sit well with me at all.
And I don't think it sits well with anybody else. But the good news is that there's immense hope
for people with long COVID
because I know there's people listening
to this podcast right now
that are suffering from long COVID,
whether they know that it's long COVID or not,
because of this diffuse myriad of symptoms.
You know, people just have a mood collapse
and it's not enough of a symptom in many cases. In some cases it is,
but it's not enough of a symptom in a lot of cases to drive someone to the ER or to say,
I have to go to urgent care. They just start to tolerate mood numbness and hormone disruption
and crushing fatigue and brain fog at a crazy level and a complete lack of libido. And they start to lose those upper
tiers of emotional states. They don't feel passionate or elated or joyful or aroused or
really, really happy anymore. So the enjoyment goes out of life. And I've seen this in thousands
of times because of our clinic system where people that are suffering from long COVID don't,
they don't have the exact same symptoms it's not
like they all get myocarditis pericarditis trigeminal neuralgia transverse myelitis
they're really hyper specific things it's sort of this diffuse myriad of muck and they just
are not themselves and they know it and sometimes they'll even describe how they're spatially kind
of disoriented like I just I don't feel like, you know,
I'm having this conversation with you,
but there's something weird about your distance from me
and how I'm interacting with you.
I don't feel very present.
I almost feel detached.
And I've heard this type of description
from hundreds and hundreds of people.
And it's amazing that there's now hope for them
to maybe detoxify from this protein. And what's really exciting, and to, to, to maybe detoxify, um, from, from this protein.
And, and what's really exciting, and I know we have to be cautious about, you know, making any
claims or going down the wrong road. Um, and we'll, we'll, we'll edit this podcast appropriately, but,
um, is that circulating tumor cells eventually become tumors. Yes. And circulating tumor cells also distract the immune
system from the nodular tumor that you may already have. Oh, that's right. And so it seems to me,
Mike, this is not only a preventative thing, this could eventually find its way into mainstream
oncology where you have patients that have metastatic tumors or they have
cancers that that are nodular or focal and but you're at least able to remove all of the other
oh yeah things that the immune system is is is is chasing these other circulating yeah so let's
let's talk about that so what's really interesting and I'm not an oncologist, but I thought when you got cancer and you got metastatic cancer,
it was a clone thing.
So you had this thing in your lung, it gets cloned a billion times,
and that same thing that was in your lung is now in your liver,
and now it's in your toes, and it's in your brain,
it's in your bones, and it's awful.
And that's not exactly what happens.
The original tumor is subdividing and mutating at a very high pace.
So the cells that go on to metastasize are colonizers. They're not the same as the original
parent. So the great, great, great, great, great, great, great grandson is Cortez, A angry colonizing cell.
The cells,
because there's an equal number of cells that are
indolent and useless, they don't
grow up to be big time cancer people.
They just die.
So the cells that kill you
are not the original.
So the really smart oncologists say,
Mink, you have to chase the met.
You don't chase the primary.
You chase the met.
The metastasis.
That's right.
Yeah, because the vast majority of cancer deaths
come from metastasization.
90% of cancer deaths are from metastatic cancer.
Okay.
And the met looks nothing like the parent.
So at some point, it's got to travel
in the blood. That's right. So when you can remove the cells in the bloodstream, which are the ones
doing the metastasizing, we slow down the metastasis. So that was the original thesis.
Then we found if you remove the cells, patients feel better because it turns out removing the
cells, when you get a bunch of cells that are dying all over the place,
because only one in a thousand,
one in 10,000 of the cells are active mets.
But when they all die,
the body's got to mop that up.
Yeah.
That's metabolically and energetically very,
it's like a bunch of zombies
walking the streets of Miami,
getting into traffic,
falling into manholes.
Someone's got to go clean that stuff
up. That's a lot of energy. So one of the things you see in cancer is cachexia. People don't eat
because they're metabolically absolutely messed up by the cancer. And they're metabolically
exhausting. Exactly. What are the top three reasons why I prefer a vertical cold plunge
versus a lay down tub? Well, I've used both. When you're in a vertical position, your body
naturally regulates your breathing better. So if you're holding on used both. When you're in a vertical position, your body naturally regulates
your breathing better. So if you're holding on to the sides and you're in a vertical position,
you can just focus on your breath work and you can stay calm. A lot of people feel more calm
when they're in a vertical position than when they're laying down in the water and think they
might slip under the water. So when you're vertical plunging, you're fully immersed faster,
you can focus on recovery, inflammation reduction, and you're not struggling to just stay in a lie down position. Your body floats in an awkward way
sometimes. So it's just a more efficient, comfortable experience in my opinion. It takes up
way less space too. It has a smaller footprint. So you can put these on your patio, your garage,
your bathroom, your locker room. You can really put it anywhere. I've got one on my balcony. I've
got two in my bathroom. So this is why cold life is my favorite cold plunge on the market. So click the link below and you can order yours today. Make
sure you get the ultimate human version. Now let's get back to the ultimate human podcast.
So I want to shift gears away from cancer for a moment. I mean, first of all, I mean,
I'm fascinated by the implications that this may have on cancer. And I want to talk about longevity,
you know, aging, because, you know, when the
immune system is worn down and distracted, right, this whole concept of, you know, the immune system
being exhausted, immunoxhaustion is, I think, what Peter Diamantis referred to. And it made,
the real light bulb went off for me. Because, you know, what is the difference between a young
person and an older person? I mean, there's been a lot more assaults on the immune system and we are bathing our
cellular biology in a toxic soup. If we could remove that toxic soup, it makes very much sense
to me that our cellular biology could thrive. What are some of the implications for longevity,
for anti-aging, for something like blood filtration. So that somebody that
doesn't have cancer or doesn't suffer from long COVID, but is really hyper-focused on
living as long, as healthy a life, having as long of a health span as possible.
So we are very interested in the fact that many things that cause problems are attracted to the inner blood vessel wall,
like oxidized LDL, advanced glycolization, end products.
We think, and we're getting to do some initial research here,
that these things are attracted to the blood vessel wall.
So if I offer up to these gamish,
a 40-meter-square surface to go get lodged into, we think we can make a huge
impact to remove that. I also think that to the degree that people have chronic antigenemia from
whatever, if we, whether it's a chronic viremia or something they have, this could impact them
in a very positive way. So the most important thing that we kind of believe
generically in medicine is what is the risk to the patient before you talk about the benefit?
And this device has been in over 2,500 patients now. It's very safe. It's as safe as a dialysis
procedure. So when you have a nice safety profile, you can move from the sickest patients in the intensive care unit, which is what we did for COVID.
And now we're moving into outpatients who have cancer, who have long COVID, chronic viremia, chronic Lyme, et cetera.
And we're now going to move exactly to where you're saying is, can we help people to treat the disease of aging?
Yes.
Okay.
And I know people don't love calling aging a disease
and I don't want to sort of get into the nomenclature,
but for many people, it is a type of disease.
And I think that this is biochemically something
we can actually start to get a handle on.
So for long COVID, it's currently a described syndrome.
If we can get spike protein levels in everybody,
you can start saying,
are you a spike protein positive long COVID or not?
And that helps us with diagnosis
and with treatment decision-making.
I think for aging,
we're getting much better at being able to profile people.
So I don't want to be in the position of use,
not even just our device,
other devices will come,
other medications will come.
We want to get more sophisticated.
And you have begun to do this, I know, in your practice,
which is, well, I'm not going to give everybody everything.
Like, what is it that's ailing you?
And let's talk about what's potentially causing it.
And for a person who is struggling or a person who wants to be optimized,
is oxidative stress their big problem?
Are they going to benefit from a hydrogen-type kind of therapy?
Or is it something else? Are they dealing with other issues? Are they, to benefit from a hydrogen type kind of therapy? Or is it something
else? Are they dealing with other issues? Is it endocrine? You want to be able to have the same
sophisticated diagnostic processes that we bring to bear for all kinds of diseases like cancer and
heart disease and sepsis into this aging piece. And I think you and Peter are actively working
on this. I think it's fantastic. Thank you.
You know, you said hydrogen,
so I've got to go down that road a little bit
because I get a lot of flack
for standing behind hydrogen water so staunchly.
And I've done tests, you know,
where I go right on social media
and I'll show people how you can reduce the ORP,
you know, improve the ORP of a fluid
by adding hydrogen gas to it.
You can use hydrogen tablets if you don't have 250 bucks to buy a hydrogen water bottle.
But what was interesting, we talked about this before you came on the podcast. I want to touch
on it for a moment. We came together mutually through a friend named David Perez. Yes.
And, but you, it was the interesting,
the pathway that you took there,
because I guess a friend of yours
sent my Joe Rogan podcast.
Yeah, so it was a very funny story.
So a friend of mine sends me a podcast
and says, there's this guy on Rogan
and he's talking about methylation and hydrogen.
Can you take a look at this and see if this is real?
And I am a Rogangan fan but i don't know
download his stuff every week i can't keep up i mean most icu
nephrologists don't i think his audience is heavy and this is not a criticism but some of them are
like three hours long and so like i don't like it's not like you can skim it like 18 holes of
golf it's a commitment no it's a commitment and so you get half for anyway so um my friend sends
it to me.
I look at it.
I see you there and you're talking about methylation and you're talking about hydrogen water.
And I'm going to be honest with you.
I told you my initial reaction is, what the F is this dude talking about?
I'm like, I have not heard of any of this.
Now, because I'm a physician, I suffer from a fair amount of arrogance.
And because I'm an academic physician, it's probably tenfold worse.
So I had an initial reaction of,
if I don't know about this, it must be nonsense.
But, you know, I looked it up
and the methylation stuff is real.
I was embarrassed I didn't know about it.
I remain embarrassed I didn't know about it.
And the hydrogen stuff is real.
And I was so motivated after I read about it.
So the hydrogen literature is over now,
I think 1500 PubMed articles, peer reviewed. The first paper about hydrogen is 2007 in Nature.
That is not like some nothing journal for people who don't follow the literature.
That Nature article is a beautiful paper. And I came to appreciate that hydrogen is a very powerful
substance but i'm going to try to explain it to folks in in my way um if you if i may to say this
is what i think so what people need to understand is you hear about alkaline water you hear about
lithium water you hear about all this water and how it's going to cure you. And I get why that initial concept bothers people because it sounds hokey. So let's not talk about where you get your
hydrogen. Let's talk about hydrogen itself. So when we're talking about hydrogen, we're talking
about the Hindenburg people. So this is hydrogen gas. The same stuff you put in a hydrogen car to
run, the same stuff that was in the Hindenburg, it's hydrogen gas.
Now, what people need to understand is that hydrogen as a gas gets dissolved in your blood, whether you drink it or you inhale it.
So it goes from a gas to being in fluid, just like carbon dioxide is in seltzer water.
So you look at the water, there's no bubbles in it.
You open it, some bubbles come out, but there's a lot of gas dissolvedeltzer water. So you look at the water, there's no bubbles in it. You open it, bubbles come out, but there's a lot of gas
dissolved in the water.
So the hydrogen gets dissolved in your blood water
and that hydrogen,
because it's small
and uncharged, rapidly
diffuses into cells,
into the endoplasmic reticulum,
into the mitochondria.
And when it does that,
it reacts with oxidative stress molecules. So when we
do a lot of things energetically with glucose, when we fight an infection, when we're inflamed,
we as mammals end up with an enormous amount of oxidative stress. And that oxidative stress and that oxidative stress is linked directly to inflammation this
is a fact hydrogen is a very potent antioxidant it is just that simple and for those people who
have a chemistry back down it is an electron receiver it is the opposite of an oxidant which
is which donates right you lose you know it's's Leo the lion goes grr. You remember that in high school chemistry?
Leo the lion goes grr.
So lose electrons is oxidation.
Gain electrons is reducing.
Yes.
Hydrogen takes electrons away.
And neutralizes.
It neutralizes superoxide, hydrogen peroxide.
This is the nature paper.
And it does it very effectively.
And so people who
take inhaled nitrogen i'm sorry inhaled hydrogen take it through um intravenous saline and it's
octa or through water are able to very safely dose themselves with a very potent antioxidant
i know that you and david others use bath profile. So it's a large surface
area to deliver hydrogen. And I would say for those people who don't believe it, I am totally
fine with you being cynical because I'm cynical about many things. Please look at PubMed and look
at some of the review articles. It's very compelling. The field for which I have many
of my publications in the field called acute kidney injury or acute renal failure. It works for that.
Wow.
There is data for ARDS.
There is data for sepsis.
There is data in Parkinson's.
It's compelling.
And one of the things I aspire to do in the next five years is to actually work in this
space.
I really think that hydrogen is a powerful tool.
Love to have you in the space.
I would love to have your expertise because many of the stories that I have seen, the lives
that have been impacted by hydrogen bathing, by hydrogen inhalation, by hydrogen drinking,
hydrogen water, I do not talk about in the public domain for fear of being so ostracized,
you know, for being a charlatan that I literally don don't even talk about it. No, what's funny is I tell my colleagues, I actually started,
I was telling, I started a review article on this,
and I sent it around to a bunch of my colleagues,
and they were just like, what is this?
I said, look at the references.
This is all in PubMed.
So hopefully this will, by the time this is-
And you sent it to, what, six, and only one is going to take it up?
It's under review right now.
It's not set to be, I feel confident it will get published eventually somewhere.
Okay.
And maybe by the time this comes out, we'll know.
Okay.
And you can put the link, but we'll see it.
And is this on bathing or drinking or?
This is just, the basic thesis is gas is medicine.
That's the title of the paper.
Great.
And I think that we use oxygen as a gas for medicine all the time.
And it's my thesis. So people don't get too upset about it. This is still hypothesis,
but I think there's very compelling data that hydrogen gas can be used effectively as a medicine.
I think there's non-trivial OSHA risks around using too much hydrogen. So don't like go to
the filling station if you have a
hydrogen car and like start doing weird stuff i don't let people smoke in my bathroom yeah i mean
like it's it's like having natural gas around you got to be thoughtful but i i really think that the
data are quite compelling and i i'm continuing to do um a lot of work in this space and i aspire to
have some published research going on this too i'm so excited about that because I look at the, you know, like you talked about earlier, the downside risk,
you know, when we refer to the blood filtration, you know, how safe of it is it to engage in this
procedure to try to get the desired outcome, but always knowing that if it doesn't work,
what's my downside, right? Which. Which, which I think is,
you know, a very, uh, untenable trade-off very often with, with, with modern medicine. It's like,
well, this is either going to fix your mood disorder or permanently change the neuroplasticity
of your brain. Um, and also not work, you know, I mean, I feel this way about some of the, um,
some of the extreme psychedelics, like I'm extreme psychedelics like i'm actually a big believer in
psilocybin and microdosing mushrooms things like that and ketamine and controlled environments
i've seen that work work miracles i actually have somebody living in my house right now that
uh suffering from absolutely brutal tinnitus the data for the psychedelics is actually quite
interesting yeah uh i mean pauline's book on how to change your mind I read, I think it's a beautiful book that talks about some of the basic research behind it.
And I think that this is not LSD in the 60s.
Exactly.
That's what I think.
And everyone thinks that when they're-
People instantly go to shroom trip that I did in college.
And these are guided with a therapist, therapeutic interventions.
And most of the time you don't trip out, right?
You're not like losing your mind.
And the dosing is very different.
Like LSD, and I mean, I wasn't alive in the 60s,
but LSD in the 60s didn't seem like a very dose-controlled environment to me, right?
You just look at the artwork that came out and you're like,
you really thought that looked good? Look at well how much of it uh half a lick this
is good yeah like yeah show a corner of it like a black lab kind of like a cat you know like you
know don't get after it i mean like yeah i mean god bless the guys who just went all in on that
i mean but i saw something on on instagram the other day. It's funny. Cause we have, we have a home in Colorado and, and, and our neighbor's like a mushroom expert and he literally cooks
the best mushrooms and it tastes like a delicacy. They, uh, but it was, you know, you got to think
at some point who was like the first dude that was wandering through the, you know, the, the,
the forest. And it was, it was a funny meme and it said, you know, well, this one tastes like beef.
Um, you know, this one killed Brian immediately. And, uh, this one made you walk with Jesus for six hours, right? Like, I don't
know who the guy was that ate it and was like, well, that was delicious. And he was fine. And
the next dude just keeled over and like, okay, mark that one. Don't, don't eat the ones with
the white, with the little polka dots, you know? Um, but I mean, we, we've advanced so much and, you know, my core interest and my childlike fascination is with extending healthspan and, you know, maybe not even necessarily lifespan.
You know, people are going to live to 82, but to live to 81 and a half, right?
Live well.
And, you know, when I was in the mortality space, it was clear to me that people started dying in their late 50s and early 60s.
They might not have left the earth until their late 70s or early 80s, but they started dying in their 60s.
And it's just completely unnecessary.
Yeah, I think it's really important to understand that we aspire to be able to have this technology available to everyone soon.
And right now, and I just want people not to get their hopes up,
this is only available in a clinical trial
for which people are able to qualify and get in.
But I just want everyone to know it's under an IRB clinical trial,
which is important, but I don't want,
I want to be able to get this to everyone as soon as I can,
but I don't want people thinking it's instantly available,
at least in the U.S., and it's available in a clinical trial. Um, and we, we are going to expand the indication. We
have a lot of work ahead of us, but I'm delighted that people are trying to, to use this to feel
better. And we're learning so much from it as we go, which is what's spectacular.
I am too. I'm really delighted about it. So I've got to ask you this question. As a physician, scientist, researcher, what is exciting you and motivating you right now? Like, where because you're excited, man, you're on fire. You
were on fire when we first started talking. I was like, there's some childlike curiosity that is
driving that inside of you. What is that? So that North star. What I think is so interesting is when
something teaches you beyond your level of education and experience. So I'm 54 now and I've been doing
medicine for a long time. I've been doing research for a long time. You don't, you don't get easily
impressed. You know, you, something has to really be like, wow, you get more cynical. That's right.
I think you start cynical and you get more cynical over time. Right. And so I think what
is interesting about this is therapeutically we think, hey, this is really cool that we can take these things out.
But what I think is the next most important value proposition scientifically is what is it that we're taking out?
So here's a very good example.
In the cancer space, right?
In the cancer space, right, in the cancer space, so we know that patients with metastatic cancer,
those cells are chemo and radiation resistant.
They evolve to be really nasty colonizing cells,
and they resist therapy.
That's why you die.
They just outrun everything.
Right.
Well, as you know, because you've done a lot of
work in this space there's no free lunch in biology so if you are going to attack you cannot
defend now when you measure things with an antibody you're using a hook to grab that epitope
and when you do it you typically kill the thing you grab what our device allows us to do is to grab virus,
bacteria,
and cancer cells intact.
So next level for us is the interrogation.
Now,
you look the way I do and you talk about interrogation,
you should be a little bit afraid.
You get to clean them up without leaving all the trash behind in the streets.
That's right.
And the idea is,
is now you can elute,
like rinse the filter,
take the stuff off and say, what is this stuff? So in cancer cells, I want to know what makes that cell so chemo resistant, because if it has to attack, it's going to have a vulnerability. Maybe we can find it. Maybe we get an ADC for it or a new kind of therapy. It's already on the shelf that no one knew would work for this. If you have some goofy virus or if I'm taking off spike protein,
well, let's take it off.
Did that spike protein interact with a new thing to create a new agent or a new particle, which happens?
Yes.
Right, because normally the spike protein is a trimer,
meaning there's three of them,
like a clover leaf that's floating around.
Well, does it grab onto something else?
That's what makes someone get long COVID
versus not having long COVID. And can we, so I think that the science for
grabbing things intact and learning from them is very powerful. Now, one of the things which
you know very well is if you are a cancer survivor, they don't ever say this, but in a
quiet moment, they will tell you every morning they wake up and they ask themselves, is today the day my cancer comes back?
And we all have loved ones who either died from cancer, who have cancer, who you're hoping never comes back.
Well, what we typically do is we PET scan them.
So we're looking to see little shoots of cancer in their body that we can see on a PET scan.
Well, what if I can look for the seeds in their blood every six months or every year?
State zero.
Wouldn't that be better?
Oh, and by the way, when I do that procedure, I clear all the seeds out.
Yeah.
Not just the cancer seeds.
That's right.
So we think we might be able, like these are early days
and I want to make it clear that
no one should be doing this for this reason yet.
We've not, but I think this is going to work for that.
I think so too.
And I think we can make a smaller filter
that's a more diagnostic one
and put it with ways that we can do a single needle
instead of like two needles
and make it really easy exactly
to make it minimally invasive for folks.
So our focus now is to go to minimally invasive,
to develop our therapy, prove it out,
and get to this diagnostic piece.
Because then I hope within, I don't know,
three to five years, you could send a patient,
they get a procedure,
and you'll get a report
from what washed off our filter and say, Gary, this is what your patient is dealing with.
Instead of measuring 85 different things that are up, down, up, down, up, down. These are the
things this patient has that are glomming onto their vascular wall because we're just a big
vascular wall with a huge surface. So whatever's glomming onto us is informative.
Not everything which attaches is necessarily pathologic,
but almost everything pathologic grabs heparin.
Wow.
So not only now is it a therapeutic decoy device,
it's a diagnostic device.
That's where I think this could go.
You know, it's astounding to me the number
of chronic diseases um multiple sclerosis uh parkinson's um alzheimer's not saying all of them
not saying everyone that is diagnosed with those diseases but how many of these are actually
chronic viral yeah or low-grade viral infection?
The HSV data with Alzheimer's is compelling.
It's very compelling.
The same is true with colon cancer.
Yes.
You know, I mean, it's very compelling.
I mean, Dr. Minkoff has been on my podcast a number of times and I've had lots of Zooms
and interaction with him, you know, rarely has colon cancer patients that are not HPV positive.
And so I think that the concept of cleaning the blood, reducing the viral load,
reducing the cytokines, allowing the immune system to, you know,
like put the windshield wipers on so we can see again,
because our best defense is the defense that God gave us.
Yes.
But it's fighting what man made us.
Yeah.
I like that.
I think that's exactly right.
And I think that subtractive therapy has a real role.
Yeah.
And we really hope to really bring this out.
It's the first time that I've ever seen anything so exciting that's subtractive and not active.
Well, first of all, this has been amazing.
I'm definitely going to have you back on the podcast.
I wind down all my podcasts by asking all my guests the same question,
and there's no right or wrong answer to this question.
What does it mean to you to be an ultimate human?
I think for me it's to be able to reach your maximum God-given impact.
We're all unique.
What's wonderful about each individual person is we're
the only one of ourselves ever. And to try and achieve the maximum impact for who you were
meant to be, and that requires a mindset and it requires trying to be in your best physical and
mental health as possible with the right intent. And one of the reasons I love Peter so much, his intent is so solid. Yeah. And he executes his intent, you know,
and I just think that he's a good example of someone who's just trying to push.
Well, Peter, a lot of love on this podcast today.
Yeah, no, Peter, I'm coming for more stuff for you guys.
Chop this up and just start throwing it out on social media, brother,
because you got a lot of love today.
Well, Dr. Chawla, thank you so much for coming on.
Oh, my pleasure.
Thank you so much for having me.
I'm definitely going to have you again.
And as always, guys, that's just science.